Adverse event [GxP / QC / QA]

posted by Bhavesh – India, 2009-08-14 07:04 (6153 d 10:39 ago) – Posting: # 4045
Views: 8,758

hi ,

I required some clarification (BA-BE studies)

In two Period study with ambulatory collection , I had performed lab investigation in check in and at check out of P-II. Also I have critera in protocol for lab investigation at last ambulatory.

I didn't get any value of lab paramenter that is significant at the time of check out lab investigation of P-II but got value significant at ambulatory lab investigation. In this case I consider it its due to drug administered. I confused bcoz it is not obtained at check out lab investigation and at that time drug concentration in body is higher than at time of ambulatory.

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
169 visitors (0 registered, 169 guests [including 22 identified bots]).
Forum time: 17:43 CEST (Europe/Vienna)

Actually, science starts to become interesting
only where it ends.    Justus von Liebig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5